Imagyn Medical Technologies

Imagyn Medical Technologies was a medical device company that specialized in the development and commercialization of products for urology, gynecology, and general surgery. Formed through the evolution of UroHealth Systems, the company focused on minimally invasive surgical solutions and oncology treatments. Its primary product lines included laparoscopic instruments and the IsoStar iodine-125 brachytherapy seeds used for treating prostate cancer. Following a period of financial restructuring and Chapter 11 bankruptcy, the company's assets were acquired by Mentor Corporation in 2004 for approximately $60 million. This acquisition allowed Mentor to strengthen its position in the urological and pelvic health markets.